Curia, a prominent global Contract Development and Manufacturing Organization (CDMO), boasts over 30 years of industry experience. Specializing in end-to-end solutions, Curia collaborates with pharmaceutical and biotech companies to facilitate the improvement of patients' lives. Their comprehensive suite of Research and Development (R&D) and manufacturing capabilities, combined with their industry-leading expertise, accelerates the journey from idea to impact.

From biologics research and development to lab testing and manufacturing, Curia offers a diverse range of services. Their expertise spans antibody discovery, formulation development, analytical testing, and rare/orphan and high potency capabilities. Curia's collaborative approach blends the science of impact with the art of possibility, aiming not only to deliver therapies but also to positively impact and change lives. As a trailblazer in CDMO, Curia continues to revolutionize the industry with its innovative and advanced capabilities, fostering groundbreaking medical breakthroughs. Join Curia to witness the latest updates and discover how you can move from idea to impact.